首页 | 本学科首页   官方微博 | 高级检索  
检索        


Successful treatment of Wernicke encephalopathy in terminally ill cancer patients: Report of 3 cases and review of the literature
Authors:Email author" target="_blank">Hideki?OnishiEmail author  Chiaki?Kawanishi  Masanari?Onose  Tomoki?Yamada  Hideyuki?Saito  Akira?Yoshida  Kazumasa?Noda
Institution:(1) Department of Psychiatry, Kanagawa Prefecture Cancer Center, 1-1-2 Nakao, Asahi-ku, 241-0815 Yokohama, Japan;(2) Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan;(3) Department of Surgery, Kanagawa Prefecture Cancer Center, 1-1-2 Nakao, Asahi-ku, 241-0815 Yokohama, Japan;(4) Department of Internal Medicine, Kanagawa Prefecture Cancer Center, 1-1-2 Nakao, Asahi-ku, 241-0815 Yokohama, Japan
Abstract:Although Wernicke encephalopathy has been reported in the oncological literature, only one terminally ill cancer patient with Wernicke encephalopathy has been reported. Wernicke encephalopathy, a potentially reversible condition, may be unrecognized in terminally ill cancer patients. In this communication, we report three terminally ill cancer patients who developed Wernicke encephalopathy. Early recognition and subsequent treatment resulted in successful palliation of delirium. Two of the three patients did not show the classical triad of Wernicke encephalopathy. Common clinical symptoms were delirium and poor nutritional status. Intravenous thiamine administration dramatically improved the symptoms of delirium in all three patients. In terminally ill cancer patients, clinicians must remain aware of the possibility of Wernicke encephalopathy when patients with a poor nutritional status present with unexplained delirium. Early intervention may correct the symptoms and prevent irreversible brain damage and the quality of life for the patient may improve.
Keywords:Vitamin B1 deficiency  Cancer  Delirium
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号